home / stock / agnpf / agnpf quote
Last: | $0.0791 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.0791 |
High: | $0 |
Low: | $0 |
Volume: | 8 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0791 | $0 | $0.0791 | $0 | $0 | 8 | 07-03-2024 |
$0.0791 | $0 | $0.0791 | $0 | $0 | 60 | 07-02-2024 |
$0.0791 | $0.082575 | $0.0791 | $0.08599 | $0.0791 | 7,260 | 07-01-2024 |
$0.082 | $0 | $0.082 | $0 | $0 | 4 | 06-26-2024 |
$0.082 | $0.0908 | $0.082 | $0.0908 | $0.082 | 298 | 06-24-2024 |
$0.0773 | $0.1042 | $0.0773 | $0.1191 | $0.0773 | 82,242 | 06-21-2024 |
$0.089441 | $0.089441 | $0.089441 | $0.089441 | $0.089441 | 4,548 | 06-20-2024 |
$0.09 | $0 | $0.09 | $0 | $0 | 1,245 | 06-18-2024 |
$0.09 | $0.09514 | $0.09 | $0.09514 | $0.09 | 472 | 06-17-2024 |
$0.09914 | $0.0962 | $0.09914 | $0.1 | $0.0928 | 19,300 | 06-14-2024 |
$0.1028 | $0.1028 | $0.1028 | $0.1028 | $0.1028 | 20,508 | 06-13-2024 |
$0.1098 | $0.1077 | $0.1098 | $0.1114 | $0.1077 | 1,980 | 06-12-2024 |
$0.11168 | $0.114 | $0.11168 | $0.114 | $0.11168 | 688 | 06-11-2024 |
$0.1161 | $0.1122 | $0.1161 | $0.1161 | $0.1122 | 570 | 06-10-2024 |
$0.101 | $0 | $0.101 | $0 | $0 | 72 | 06-07-2024 |
$0.101 | $0.101 | $0.101 | $0.101 | $0.101 | 228 | 06-06-2024 |
$0.11 | $0.1049 | $0.11 | $0.11 | $0.1049 | 400 | 06-04-2024 |
$0.115025 | $0 | $0.115025 | $0 | $0 | 120 | 06-03-2024 |
$0.115025 | $0.115025 | $0.115025 | $0.115025 | $0.115025 | 1,024 | 05-31-2024 |
$0.1102 | $0.1054 | $0.1102 | $0.1102 | $0.1054 | 504 | 05-30-2024 |
News, Short Squeeze, Breakout and More Instantly...
Algernon Pharmaceuticals Inc - Class A Company Name:
AGNPF Stock Symbol:
OTCMKTS Market:
Algernon Pharmaceuticals Inc - Class A Website:
VANCOUVER, British Columbia, May 21, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it ha...
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its...
VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to invite investors and other interested parties to participate in an upcoming speci...